Biotalys announced the strong performance of its first protein-based biofungicide Evoca?* in independent efficacy field trials conducted by a number of highly reputed public institutes in 2021. Evoca? is aimed at providing fruit and vegetable growers with a new rotation partner in integrated pest management programs to help control devastating fungal diseases such as Botrytis and powdery mildew, reducing dependency on chemical pesticides and corresponding residues in harvested produce and offering a distinctive new tool to manage pathogen resistance development. The extension trials for grapes and strawberries, conducted by a number of prestigious independent academic institutions in the United States, are industry gold-standard studies which provide growers and crop advisors with detailed information on the performance of existing and pipeline crop protection products. In all of the trials conducted in 2021, the final commercial formulation of Evoca? was tested among many other treatments and non-treated control plots, enabling the comparison of its performance with conventional chemical and biological fungicide products. Full results of these trials are being made public by the respective institutions.